Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 10 (RPL36P10)

Target
RPL36P10
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L36 pseudogene 10 (RPL36P10) is a processed pseudogene derived from the ribosomal protein L36 gene family.[5][6] Pseudogenes like RPL36P10 arise due to events such as gene duplication or retrotransposition but typically lack the ability to encode functional proteins due to mutations or absence of regulatory elements. As with most ribosomal protein pseudogenes, RPL36P10 is not transcribed into a functional protein, nor is there evidence it has a biological role or is involved in disease. It is not considered a therapeutic target, and no drugs are known to interact with this locus.[5][6] RPL36P10 is distinct from the functional RPL36 gene, which encodes a protein component of the 60S ribosomal subunit important for translation.[1][2] Processed pseudogenes such as RPL36P10 are widespread in the human genome, resulting largely from the retrotransposition of mRNA from protein-coding genes.[3] The presence of many ribosomal protein pseudogenes can complicate gene expression analyses and bioinformatics due to sequence similarity, but these pseudogenes themselves have no known physiological or pathological activity.[3] RPL36P10, as a pseudogene, does not encode a protein, does not participate in biological pathways, does not serve as a disease target or biomarker, and has no known functional or pathological impact in humans. It is included in various gene databases for genome annotation, but it is not relevant to therapeutic targeting or drug discovery.[5][6]

Other names
RPL36_3_697RPL36P10[6][5]

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 10 (RPL36P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 10 (RPL36P10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call